Search research articles
Contact Us
Filters
Showing results (51-60 of 144) with videos related to
Page
of 15
Sort By:
BMJ Open Diabetes Research & Care
|
June 25, 2021
Secondary metformin monotherapy failure in individuals with type 2 diabetes mellitus
Tracey Weiss, Kristy Iglay, Tania Gulati, et al.
Diabetes, Obesity & Metabolism
|
June 16, 2021
Efficacy of liraglutide added to sodium-glucose cotransporter-2 inhibitors in type 2 diabetes, stratified by baseline characteristics: Post-hoc analysis of LIRA-ADD2SGLT2i
Lawrence Blonde, Udi Fainberg, Margit S Kaltoft, et al.
Clinical Therapeutics
|
March 22, 2015
Diabetes-Related Composite Quality End Point Attainment: Canagliflozin Versus Sitagliptin Based on a Pooled Analysis of 2 Clinical Trials
Robert A Bailey, Ujjwala Vijapurkar, Gary Meininger, et al.
Diabetes, Obesity & Metabolism
|
December 6, 2017
Clinical correlates of hypoglycaemia over 4 years in people with type 2 diabetes starting insulin: An analysis from the CREDIT study
Philip Home, Francoise Calvi-Gries, Lawrence Blonde, et al.
Diabetes Care
|
May 22, 2016
Getting to the "Heart" of the Matter on Diabetic Cardiovascular Disease: "Thanks for the Memory"
William T Cefalu, Julio Rosenstock, Derek LeRoith, et al.
BMC Health Services Research
|
August 7, 2016
A post-hoc analysis of the comparative efficacy of canagliflozin and glimepiride in the attainment of type 2 diabetes-related quality measures
Charmi A Patel, Robert A Bailey, Ujjwala Vijapurkar, et al.
Current Medical Research and Opinion
|
March 30, 2018
A real-world analysis of glycemic control among patients with type 2 diabetes treated with canagliflozin versus dapagliflozin
Lawrence Blonde, Charmi Patel, Brahim Bookhart, et al.
Diabetes & Vascular Disease Research
|
April 7, 2010
What are the practical implications for treating diabetes in light of recent evidence? Updated recommendations from the Global Partnership for Effective Diabetes Management
Clifford J Bailey, Lawrence Blonde, Stefano Del Prato, et al.
Diabetes & Vascular Disease Research
|
May 4, 2017
Gaps and barriers in the control of blood glucose in people with type 2 diabetes
Lawrence Blonde, Pablo Aschner, Clifford Bailey, et al.
Diabetes, Obesity & Metabolism
|
October 22, 2016
Predictors of outcomes in patients with type 2 diabetes in the lixisenatide GetGoal clinical trials
Lawrence Blonde, Pavan Chava, Terry Dex, et al.
Page
of 15
Search research articles
Search
Showing results (51-60 of 144) with videos related to
Sort By:
Page
of 15
BMJ Open Diabetes Research & Care
|
June 25, 2021
Secondary metformin monotherapy failure in individuals with type 2 diabetes mellitus
Tracey Weiss, Kristy Iglay, Tania Gulati, et al.
Diabetes, Obesity & Metabolism
|
June 16, 2021
Efficacy of liraglutide added to sodium-glucose cotransporter-2 inhibitors in type 2 diabetes, stratified by baseline characteristics: Post-hoc analysis of LIRA-ADD2SGLT2i
Lawrence Blonde, Udi Fainberg, Margit S Kaltoft, et al.
Clinical Therapeutics
|
March 22, 2015
Diabetes-Related Composite Quality End Point Attainment: Canagliflozin Versus Sitagliptin Based on a Pooled Analysis of 2 Clinical Trials
Robert A Bailey, Ujjwala Vijapurkar, Gary Meininger, et al.
Diabetes, Obesity & Metabolism
|
December 6, 2017
Clinical correlates of hypoglycaemia over 4 years in people with type 2 diabetes starting insulin: An analysis from the CREDIT study
Philip Home, Francoise Calvi-Gries, Lawrence Blonde, et al.
Diabetes Care
|
May 22, 2016
Getting to the "Heart" of the Matter on Diabetic Cardiovascular Disease: "Thanks for the Memory"
William T Cefalu, Julio Rosenstock, Derek LeRoith, et al.
BMC Health Services Research
|
August 7, 2016
A post-hoc analysis of the comparative efficacy of canagliflozin and glimepiride in the attainment of type 2 diabetes-related quality measures
Charmi A Patel, Robert A Bailey, Ujjwala Vijapurkar, et al.
Current Medical Research and Opinion
|
March 30, 2018
A real-world analysis of glycemic control among patients with type 2 diabetes treated with canagliflozin versus dapagliflozin
Lawrence Blonde, Charmi Patel, Brahim Bookhart, et al.
Diabetes & Vascular Disease Research
|
April 7, 2010
What are the practical implications for treating diabetes in light of recent evidence? Updated recommendations from the Global Partnership for Effective Diabetes Management
Clifford J Bailey, Lawrence Blonde, Stefano Del Prato, et al.
Diabetes & Vascular Disease Research
|
May 4, 2017
Gaps and barriers in the control of blood glucose in people with type 2 diabetes
Lawrence Blonde, Pablo Aschner, Clifford Bailey, et al.
Diabetes, Obesity & Metabolism
|
October 22, 2016
Predictors of outcomes in patients with type 2 diabetes in the lixisenatide GetGoal clinical trials
Lawrence Blonde, Pavan Chava, Terry Dex, et al.
Page
of 15